KR101981181B1 - Method for fermented Gastrodia elata BL using lactic acid bacteria - Google Patents
Method for fermented Gastrodia elata BL using lactic acid bacteria Download PDFInfo
- Publication number
- KR101981181B1 KR101981181B1 KR1020180105154A KR20180105154A KR101981181B1 KR 101981181 B1 KR101981181 B1 KR 101981181B1 KR 1020180105154 A KR1020180105154 A KR 1020180105154A KR 20180105154 A KR20180105154 A KR 20180105154A KR 101981181 B1 KR101981181 B1 KR 101981181B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- cheonma
- sample
- lactic acid
- acid bacteria
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 241000894006 Bacteria Species 0.000 title claims abstract description 19
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 19
- 239000004310 lactic acid Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title abstract description 17
- 241000305491 Gastrodia elata Species 0.000 title description 2
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 claims abstract description 58
- 235000013330 chicken meat Nutrition 0.000 claims abstract 2
- 235000013372 meat Nutrition 0.000 claims abstract 2
- 239000000843 powder Substances 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 241000186612 Lactobacillus sakei Species 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 229940112822 chewing gum Drugs 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000000855 fermentation Methods 0.000 abstract description 20
- 230000004151 fermentation Effects 0.000 abstract description 20
- 235000013824 polyphenols Nutrition 0.000 abstract description 10
- 229930003935 flavonoid Natural products 0.000 abstract description 9
- 150000002215 flavonoids Chemical class 0.000 abstract description 9
- 235000017173 flavonoids Nutrition 0.000 abstract description 9
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 9
- 235000013305 food Nutrition 0.000 abstract description 8
- 230000003078 antioxidant effect Effects 0.000 abstract description 6
- 239000002994 raw material Substances 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 3
- 241000157282 Aesculus Species 0.000 abstract 3
- 235000010181 horse chestnut Nutrition 0.000 abstract 3
- 241001070941 Castanea Species 0.000 abstract 1
- 235000014036 Castanea Nutrition 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 51
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- 239000000796 flavoring agent Substances 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 19
- BVJSUAQZOZWCKN-UHFFFAOYSA-N p-hydroxybenzyl alcohol Chemical compound OCC1=CC=C(O)C=C1 BVJSUAQZOZWCKN-UHFFFAOYSA-N 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000004458 analytical method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 10
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 10
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 9
- 241000186191 Pediococcus inopinatus Species 0.000 description 9
- 238000004817 gas chromatography Methods 0.000 description 9
- 229930193974 gastrodin Natural products 0.000 description 9
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 9
- 240000006024 Lactobacillus plantarum Species 0.000 description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 229940072205 lactobacillus plantarum Drugs 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 102000042567 non-coding RNA Human genes 0.000 description 6
- 230000001953 sensory effect Effects 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 238000011088 calibration curve Methods 0.000 description 5
- 229960004132 diethyl ether Drugs 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- 238000001256 steam distillation Methods 0.000 description 5
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 4
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 4
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 4
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 4
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 239000005350 fused silica glass Substances 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- KMVWNDHKTPHDMT-UHFFFAOYSA-N 2,4,6-tripyridin-2-yl-1,3,5-triazine Chemical compound N1=CC=CC=C1C1=NC(C=2N=CC=CC=2)=NC(C=2N=CC=CC=2)=N1 KMVWNDHKTPHDMT-UHFFFAOYSA-N 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 3
- 238000002376 fluorescence recovery after photobleaching Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000012254 powdered material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 101710110539 Probable butyrate kinase 1 Proteins 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000021067 refined food Nutrition 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- LQERIDTXQFOHKA-UHFFFAOYSA-N nonadecane Chemical compound CCCCCCCCCCCCCCCCCCC LQERIDTXQFOHKA-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229930182487 phenolic glycoside Natural products 0.000 description 1
- 150000007950 phenolic glycosides Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
- A23B7/00—Preservation or chemical ripening of fruit or vegetables
- A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
- A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
- A23B7/154—Organic compounds; Microorganisms; Enzymes
- A23B7/155—Microorganisms; Enzymes; Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/28—Removal of unwanted matter, e.g. deodorisation or detoxification using microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- A23Y2220/67—
-
- A23Y2220/77—
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 유산균을 이용한 발효천마에 관한 것으로, 구체적으로는 유산균을 이용하여 천마를 발효함으로써 천마의 이취(異臭, 불쾌치)를 제거하는 방법에 관한 것이다. 본 발명에 따르면, 발효과정에 천마 특유의 이취를 유발하는 p-크레졸의 함량이 감소하여 기호도가 향상된다. 또한, 이취가 제거된 발효천마는 우수한 항산화 효과를 나타내며, 발효천마 내 유용성분, 총 플라보노이드 함량 및 총 폴리페놀 함량이 발효하지 않은 천마에 비해 현저히 높은 것을 확인하였으므로, 본 발명에 따른 이취가 제거된 발효천마는 고부가가치 식품 또는 건강기능식품의 원료로써 유용하게 사용할 수 있다.The present invention relates to a fermented chicken meat using lactic acid bacteria, and more particularly, to a method for fermenting a horse chestnut using lactic acid bacteria to remove odor and unpleasantness of the horse meat. According to the present invention, the content of p-cresol which causes odor peculiar to the gum is reduced during the fermentation process, and the preference degree is improved. In addition, the fermented horse chestnut having the odor removed showed excellent antioxidative effect, and the useful components, the total flavonoid contents, and the total polyphenol contents in the fermented chestnut were significantly higher than those of the fermented non-fermented horse, Fermented horse chestnut can be usefully used as a raw material for high value-added food or health functional food.
Description
본 발명은 유산균을 이용한 발효천마에 관한 것으로, 구체적으로는 유산균을 이용하여 천마를 발효함으로써 천마의 이취(異臭, 불쾌치)를 제거하는 방법에 관한 것이다.The present invention relates to a fermented cheonma using lactic acid bacteria, and specifically relates to a method of removing off-flavor of cheonma by fermenting cheonma using lactic acid bacteria.
천마는 신초(神草), 정풍초(定風草) 등의 다른 명칭으로 부르기도 한다. 신농본초경에는 천마가 중품으로 분류되어 있으며, 약성이 평무독한 약재로 알려져 있다.Chunma is also called by other names such as Shincho (神草) and Jeongpungcho (定風草). In the Shinnongbonchogyeong, Cheonma is classified as a heavy product, and its medicinal properties are known as a medicinal material that is perfectly poisonous.
천마의 임상적 효능들은 본초강목, 동의보감을 비롯한 여러 본초문헌들에 널리 기록되어 있는데 주로 고혈압, 두통, 마비, 신경성 질환, 당뇨병 등의 성인병과 스트레스, 피로 등의 증상에 대하여 효능이 있는 것으로 알려져 있다. 천마에 함유되어 있는 성분은 대부분 페놀성 화합물로서 가스트로딘(gastrodin), 페놀성 배당체, 유황 함유 페놀성 화합물, 유기산, 당 및 베타-시토스테롤(β-sitosterol) 등이 분리되어 보고되었으며, 그 이외에도 스테롤(sterol)류, 콜레스테롤(cholesterol), p-하이드록시벤질 알콜(p-hydroxylbenvyl alcohol)과 바닐린(vanillin) 등의 성분에 대해서도 알려져 있다.The clinical efficacy of Chunma is widely recorded in various herbal literatures including Bonchogangmok and Donguibogam. It is known to be effective against adult diseases such as high blood pressure, headache, paralysis, neurological diseases, diabetes, and symptoms such as stress and fatigue. . Most of the ingredients contained in Cheonma are phenolic compounds, and gastrodin, phenolic glycosides, sulfur-containing phenolic compounds, organic acids, sugars, and beta-sitosterol have been reported separately. Components such as (sterol), cholesterol, p-hydroxylbenvyl alcohol and vanillin are also known.
생천마의 수분함량은 81.2 %이며, 동결건조 시료의 일반성분은 조단백질 6.21 %, 조지방 1.50 %, 조회분 2.55 %, 탄수화물 89.74 % 함유되어 있는 것으로 알려져 있다. 천마에 대한 연구로는 천마의 일반성분과 기능성 조사(정현서, 지근억, 한국식품과학회지, 28(1), 53-57, 1996), 천마의 식품학적 성분분석 및 건조방법에 따른 특성 변화(이부용, 최현선, 황진봉, 한국식품과학회지, 34(1), 37-42, 2002), 천마추출물의 성분분석 및 인 비트로(in vitro) 생물활성에 관한 연구(강태수, 공영준, 권혜정, 최병곤, 홍정기, 박용길, 한국균학회지, 30(2), 136-141, 2002) 등의 보고가 있을 뿐이다. 78년 전부터 천마가 국내농가에서 인공재배 되기 시작하여 최근에는 약용으로의 수요를 초과하는 공급과잉현상을 나타내어 천마의 활용에 대한 제고가 시급한 상황이지만 그동안 천마는 식품의약품안전청에 의해 식품으로 사용할 수 없는 원료의 규제에 묶여서 가공식품으로의 이용이 제한되어 왔었다. 그러나 2000년 9월 1일부터 규제가 풀려서 식품원료로의 사용이 가능해짐에 따라 가공식품으로의 개발에 필요한 기초 자료가 시급한 실정이다.It is known that the water content of Saengcheonma is 81.2%, and the general components of the freeze-dried sample contain 6.21% crude protein, 1.50% crude fat, 2.55% crude ash, and 89.74% carbohydrates. Studies on Cheonma include investigation of general ingredients and functionality of Cheonma (Jeong Hyeon-seo, Ji Geun-eok, Korean Journal of Food Science and Technology, 28(1), 53-57, 1996), analysis of food ingredients of Cheonma and changes in characteristics according to drying method (Booyong Lee , Hyunseon Choi, Jinbong Hwang, Journal of the Korean Society of Food Science and Technology, 34(1), 37-42, 2002), A study on the composition analysis and in vitro biological activity of Chunma extract (Taesu Kang, Youngjun Kong, Hyejeong Kwon, Byunggon Choi, and Jeongki Hong , Park Yong-Gil, Journal of the Korean Mycology Society, 30(2), 136-141, 2002). Chunma began to be cultivated artificially in domestic farms from 78 years ago, and recently showed an oversupply phenomenon that exceeds the demand for medicinal purposes, so there is an urgent need to improve the use of Chunma. Due to restrictions on raw materials, the use of processed foods has been restricted. However, as the regulations were lifted from September 1, 2000 and can be used as food raw materials, basic data necessary for the development of processed foods are urgently needed.
또한, 천마는 식품이나 건강기능성 소재로 사용하기에 부적합할 정도의 특유의 이취(pig feces, swine barn-like)를 지니고 있으나 그의 주요 원인성분에 대해서는 구체적으로 알려져 있지 않다.In addition, Chunma has a peculiar off-flavor (pig feces, swine barn-like) that is unsuitable for use as a food or health functional material, but its main causative component is not specifically known.
이에, 본 발명자들은 천마의 이취에 대한 주요 원인성분을 밝히고 이의 함량을 감소시키는 발효 방법을 개발함으로써 본 발명을 완성하였다.Accordingly, the present inventors have completed the present invention by identifying the main causative components for off-flavor of Cheonma and developing a fermentation method for reducing the content thereof.
본 발명의 목적은 유산균을 이용한 발효천마의 제조방법을 제공하는 것이다.It is an object of the present invention to provide a method for producing fermented cheonma using lactic acid bacteria.
본 발명의 다른 목적은 본 발명의 방법에 따라 이취가 제거된 발효천마를 제공하는 것이다.Another object of the present invention is to provide a fermented cheonma from which off-flavor is removed according to the method of the present invention.
상기 과제를 해결하기 위하여, 본 발명은 유산균을 이용한 발효천마의 제조방법으로,In order to solve the above problems, the present invention is a method for producing fermented cheonma using lactic acid bacteria,
천마 분말을 증자하는 단계; Increasing the cheonma powder;
상기 증자된 천마 분말을 당화하는 단계; Saccharifying the increased cheonma powder;
상기 당화된 천마 분말을 살균하는 단계; 및 Sterilizing the saccharified cheonma powder; And
상기 살균된 천마 분말에 유산균을 접종하여 발효하는 단계;를 포함하는 유산균을 이용한 발효천마의 제조방법을 제공한다.It provides a method for producing a fermented cheonma using lactic acid bacteria comprising; inoculating and fermenting lactic acid bacteria in the sterilized cheonma powder.
상기 유산균은 Lactobacillus plantarum VL-1, Pediococcus inopinatus BK-3(기탁번호 KACC91859P), Lactobacillus sakei C-11(기탁번호 KACC91863P)인 것일 수 있다.The lactic acid bacteria may be Lactobacillus plantarum VL-1, Pediococcus inopinatus BK-3 (accession number KACC91859P), Lactobacillus sakei C-11 (accession number KACC91863P).
상기 유산균은 Lactobacillus sakei C-11(기탁번호 KACC91863P)인 것일 수 있다.The lactic acid bacteria may be Lactobacillus sakei C-11 (accession number KACC91863P).
상기 발효하는 단계에서 발효 기간은 1 내지 8일인 것일 수 있다.In the fermenting step, the fermentation period may be 1 to 8 days.
본 발명은 본 발명에 따른 방법으로 이취가 제거된 발효천마를 제공한다.The present invention provides a fermented cheonma from which off-flavor is removed by the method according to the present invention.
본 발명에 따르면, 발효과정에 천마 특유의 이취를 유발하는 p-크레졸의 함량이 감소하여 기호도가 향상된다. 또한, 이취가 제거된 발효천마는 우수한 항산화 효과를 나타내며, 발효천마 내 유용성분, 총 플라보노이드 함량 및 총 폴리페놀 함량이 발효하지 않은 천마에 비해 현저히 높은 것을 확인하였으므로, 본 발명에 따른 이취가 제거된 발효천마는 고부가가치 식품 또는 건강기능식품의 원료로써 유용하게 사용할 수 있다.According to the present invention, the content of p-cresol, which causes off-flavor peculiar to Cheonma during fermentation, is reduced, thereby improving preference. In addition, since it was confirmed that the fermented cheonma from which off-flavor was removed exhibits excellent antioxidant effect, the useful components, total flavonoid content, and total polyphenol content in the fermented cheonma were significantly higher than that of unfermented cheonma. Fermented cheonma can be usefully used as a raw material for high value-added foods or health functional foods.
도 1은 천마를 수증기 증유에 의해 얻어진 휘발성 분획(상단)과, 이를 실리카 겔 크로마토그래피에 의해 얻어진 분획 중 강한 이취를 발현하는 분획(중간) 및 표준품 p-크레졸(하단)을 분석한 GC를 나타낸 도이다.
도 2는 천마 및 표준품 p-크레졸의 GC 분석에 대한 매스 스펙트럼(mass spectrum, MS)을 비교한 도이다; A: 천마에서 검출된 p-크레졸 유사 성분의 MS, B: 표준품 p-크레졸의 MS.
도 3은 p-크레졸 정량을 위한 검량 곡선 작성 결과를 나타낸 도이다.
도 4는 대조구(천마 분말) 시료 내 유용성분을 HPLC 분석한 결과를 나타낸 도이다; 1: gastrodin, 2: 4-hydroxybenzyl alcohol.
도 5는 대조구(천마 분말)와 8일 발효한 발효천마 시료 내 유용성분을 HPLC 분석한 결과를 나타낸 도이다; 1: gastrodin, 2: 4-hydroxybenzyl alcohol.
도 6은 Lactobacillus sakei C-11 균주의 16s ribosomal RNA 유전자의 염기서열 일부(서열번호 1)이다.
도 7은 Pediococcus inopinatus BK-3 균주의 16s ribosomal RNA 유전자의 염기서열 일부(서열번호 2)이다.
도 8은 Lactobacillus plantarum VL-1 균주의 16s ribosomal RNA 유전자의 염기서열 일부(서열번호 3)이다.Figure 1 shows the GC obtained by analyzing the volatile fraction obtained by steam distillation of Cheonma (top) and the fraction (middle) expressing a strong off-flavor among the fractions obtained by silica gel chromatography and the standard p-cresol (bottom). It is a degree.
2 is a diagram comparing mass spectrum (MS) for GC analysis of Chunma and standard p-cresol; A: MS of p-cresol-like components detected in Chunma, B: MS of standard p-cresol.
3 is a diagram showing the result of preparing a calibration curve for quantifying p-cresol.
4 is a diagram showing the results of HPLC analysis of useful components in a control (cheonma powder) sample; 1: gastrodin, 2: 4-hydroxybenzyl alcohol.
5 is a diagram showing the results of HPLC analysis of useful components in a control (cheonma powder) and a fermented cheonma sample fermented for 8 days; 1: gastrodin, 2: 4-hydroxybenzyl alcohol.
6 is a partial nucleotide sequence of the 16s ribosomal RNA gene of Lactobacillus sakei C-11 strain (SEQ ID NO: 1).
7 is a partial nucleotide sequence of the 16s ribosomal RNA gene of Pediococcus inopinatus BK-3 strain (SEQ ID NO: 2).
8 is a partial nucleotide sequence of the 16s ribosomal RNA gene of Lactobacillus plantarum VL-1 strain (SEQ ID NO: 3).
본 발명은 유산균을 이용한 발효천마의 제조방법으로, 천마 분말을 증자하는 단계; 상기 증자된 천마 분말을 당화하는 단계; 상기 당화된 천마 분말을 살균하는 단계; 및 상기 살균된 천마 분말에 유산균을 접종하여 발효하는 단계;를 포함하는 유산균을 이용한 발효천마의 제조방법을 제공한다.The present invention is a method for producing fermented cheonma using lactic acid bacteria, comprising: increasing cheonma powder; Saccharifying the increased cheonma powder; Sterilizing the saccharified cheonma powder; And inoculating and fermenting the sterilized cheonma powder with lactic acid bacteria.
상기 유산균은 Lactobacillus plantarum VL-1, Pediococcus inopinatus BK-3(기탁번호 KACC91859P), Lactobacillus sakei C-11(기탁번호 KACC91863P)인 것일 수 있으며, 바람직하게는 Lactobacillus sakei C-11(기탁번호 KACC91863P)인 것일 수 있다.The lactic acid bacteria may be Lactobacillus plantarum VL-1, Pediococcus inopinatus BK-3 (accession number KACC91859P), Lactobacillus sakei C-11 (accession number KACC91863P), preferably Lactobacillus sakei C-11 (accession number KACC91863P). I can.
상기 Lactobacillus plantarum VL-1은 Lactobacillus plantarum JBARES VL-1이라는 명칭으로 NCBI에 등록번호 KX622695로 등록되었으며, 상기 Pediococcus inopinatus BK-3(기탁번호 KACC91859P)은 유전자은행에 Pediococcus inopinatus BK-1로 등록되었다.The Lactobacillus plantarum VL-1 was registered in NCBI under the name of Lactobacillus plantarum JBARES VL-1 under the registration number KX622695, and the Pediococcus inopinatus BK-3 (accession number KACC91859P) was registered as Pediococcus inopinatus BK-1 in the gene bank.
본 발명의 일실시예에서, 발효천마 중의 p-크레졸 함량을 분석한 결과, 대조구(천마 분말)에 비해 발효천마 시료에서 p-크레졸 함량이 낮았으며, 특히, C-11을 이용한 발효천마 시료에서 p-크레졸 함량이 가장 낮았다.In one embodiment of the present invention, as a result of analyzing the p-cresol content in fermented cheonma, the p-cresol content was lower in the fermented cheonma sample compared to the control (cheonma powder), and in particular, in the fermented cheonma sample using C-11 The p-cresol content was the lowest.
용어 "p-크레졸(p-cresol)"이란, 4-methylphenol로도 명명되는 화합물로, 매우 낮은 농도에서도 특징적이면서 강한 냄새를 생성한다. 본 발명의 일실시예에서, 천마를 수증기 증류하여 얻어진 휘발성 분획 및 실리카 겔 크로마토그래피(silica gel chromatography) 분획 중 강한 이취를 함유하는 분획에서 표준품 p-크레졸과 일치하는 큰 피크가 검출되었다. 또한, 관능평가에 의해 p-크레졸 표준품과 강한 이취를 함유하는 분획의 냄새 특성을 비교한 결과, 강한 이취를 함유하는 분획에서 발현되는 특유의 이취는 p-크레졸과 유사한 냄새를 지니고 있음을 확인하였다. 따라서, 본 발명에서는 이와 같은 이취가 제거되어 사용자가 용이하게 취식할 수 있는 발효천마를 제조하는 방법을 제공한다.The term "p-cresol" is a compound also named 4-methylphenol, and produces a characteristic and strong odor even at very low concentrations. In one embodiment of the present invention, a large peak coinciding with the standard p-cresol was detected in the fraction containing a strong off-flavor among the volatile fraction obtained by steam distillation of Cheonma and the silica gel chromatography fraction. In addition, as a result of comparing the odor characteristics of the p-cresol standard product and the fraction containing a strong off-odor by sensory evaluation, it was confirmed that the characteristic off-odor expressed in the fraction containing a strong off-odor had a odor similar to p-cresol. . Accordingly, the present invention provides a method of manufacturing a fermented cheonma, which can be easily eaten by a user because such off-flavor is removed.
상기 천마 분말은 천마 분말 외에도 식용가능한 곡물 또는 작물의 분말을 포함할 수 있으며, 바람직하게는 발아현미, 흑미, 율무 및 자색고구마로 이루어지는 군으로부터 선택되는 어느 하나 이상의 분말 재료를 포함할 수 있으나, 이로 한정되지 않는다.The cheonma powder may include edible grains or powders of crops in addition to cheonma powder, and may preferably include any one or more powdered materials selected from the group consisting of germinated brown rice, black rice, adlay and purple sweet potatoes. Not limited.
상기 분말 재료의 전체 중량에 있어서, 천마 분말는 30 내지 100 중량%인 것일 수 있으나, 이에 한정되지 않는다.With respect to the total weight of the powdered material, the cheonma powder may be 30 to 100% by weight, but is not limited thereto.
상기 발효하는 단계에서 발효 기간은 1 내지 8일인 것일 수 있으며, 바람직하게는 1 내지 4일인 것일 수 있고, 보다 바람직하게는 1 내지 2일인 것일 수 있다.In the fermenting step, the fermentation period may be 1 to 8 days, preferably 1 to 4 days, and more preferably 1 to 2 days.
본 발명의 일실시예에서, 발효하지 않은 대조구(천마 분말)에 비해 0~8일간 발효한 발효천마 분말 시료에서 p-크레졸 함량이 현저히 낮은 것을 확인하였다.In one embodiment of the present invention, it was confirmed that the p-cresol content was significantly lower in the fermented cheonma powder sample fermented for 0 to 8 days compared to the non-fermented control (cheonma powder).
본 발명은 본 발명에 따른 방법으로 이취가 제거된 발효천마를 제공한다.The present invention provides a fermented cheonma from which off-flavor is removed by the method according to the present invention.
본 발명의 일실시예에서, 본 발명에 따른 방법으로 이취가 제거된 발효천마는 천마 내 유용성분인 가스트로딘(gastrodin), 4-하이드록시벤질 알코올(4-hydroxybenzyl alcohol), 총 폴리페놀 및 총 플라보노이드 함량이 발효 기간동안 증가하고 항산화 효과가 발효되지 않은 천마에 비해 현저히 높은 것으로 나타났다.In one embodiment of the present invention, the fermented cheonma from which off-flavor is removed by the method according to the present invention is gastrodin, 4-hydroxybenzyl alcohol, which are useful components in cheonma, total polyphenols and total The flavonoid content increased during the fermentation period, and the antioxidant effect was found to be significantly higher than that of unfermented Chunma.
이에, 본 발명에 따른 이취가 제거된 발효천마는 고부가가치 식품 또는 건강기능식품의 원료로써 유용하게 사용할 수 있다.Accordingly, the fermented cheonma from which off-flavor is removed according to the present invention can be usefully used as a raw material for high value-added foods or health functional foods.
또한, 본 발명에 따른 이취 제거 방법은 천마 내 이취를 제거하면서 동시에 유용성분 및 이에 따른 항산화 효과를 증가시키는 현저한 효과가 있다.In addition, the off-flavor removal method according to the present invention has a remarkable effect of increasing the useful components and thus the antioxidant effect while removing off-flavor in the cheonma.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to aid understanding of the present invention. However, the following examples are merely illustrative of the contents of the present invention, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more completely describe the present invention to those of ordinary skill in the art.
<실시예 1> 천마 내 이취성분 분리 및 동정<Example 1> Isolation and identification of off-flavor components in Cheonma
1-1. 휘발성 성분 분리1-1. Separation of volatile components
동결건조된 천마의 휘발성 성분은 Schultz 등의 방법(Isolation of volatile components from a model system, J. Agric. Food Chem. 25:446, 1997)에 따라 SDE(Likens & Nickerson type simultaneous steam distillation and extraction) 방법으로 분리하였다. 구체적으로, 시료 100 g과 증류수 2 L를 둥근바닥 플라스크에 넣고 SDE 장치를 연결한 다음 2시간 증류하였으며, 이때 휘발성 성분 회수용 용매는 n-펜탄(n-pentane):디에틸에테르(diethyl ether) (1:1) 혼합액 50 mL를 사용하였다.The volatile components of lyophilized cheonma are SDE (Likens & Nickerson type simultaneous steam distillation and extraction) method according to Schultz et al. (Isolation of volatile components from a model system, J. Agric. Food Chem. 25:446, 1997). Separated by. Specifically, 100 g of a sample and 2 L of distilled water were placed in a round-bottom flask, connected to an SDE device, and distilled for 2 hours. At this time, the solvent for recovering volatile components was n-pentane: diethyl ether. (1:1) 50 mL of the mixed solution was used.
1-2. 이취성분 분획1-2. Off-flavor fraction
1-1에서 SDE법으로 분리한 휘발성 성분을 분획하기 위하여, 실리카 겔 칼럼 크로마토그래피(silica gel column chromatography) 분획을 수행하였다. 구체적으로, 실리카 겔(silica gel)(230-400 mesh) 70 g을 충진한 칼럼(3.0 cm x 20 cm)에 휘발성 성분 용매를 로딩(loading)한 후 n-헥산(n-hexane):디에틸에테르(diethyl ether) (50~95:5~50, 표 1) 혼합액 50 mL 또는 아세트산에틸(ethyl acetate) 50 mL를 사용하여 점차 극성을 높여가면서 용출하여 분획하였다. 이후 관능평가를 통해 이취 함유 여부를 조사한 뒤 천마 특유의 이취가 강하게 발현되는 분획을 GC(gas chromatography) 방법으로 분석하였다. In order to fractionate the volatile components separated by the SDE method in 1-1, silica gel column chromatography fractionation was performed. Specifically, after loading a volatile solvent into a column (3.0 cm x 20 cm) filled with 70 g of silica gel (230-400 mesh), n-hexane: diethyl Ether (50 ~ 95: 5 ~ 50, Table 1) 50 mL of a mixed solution or 50 mL of ethyl acetate was used to gradually increase the polarity, eluting and fractionation. Thereafter, the presence or absence of off-flavor was investigated through sensory evaluation, and the fraction in which off-flavor peculiar to Cheonma was strongly expressed was analyzed by GC (gas chromatography) method.
1-3. 관능평가1-3. Sensory evaluation
관능평가 요원은 20세 이상의 대학생 남녀 3명씩으로 구성하고, 1-2에서 수득한 각 실리카 겔 칼럼 크로마토그래피 분획 소량을 종이(smelling paper)에 적신 다음 용매를 휘발시키고 관능평가 요원에게 제시하여 묘사법(profile test)에 의해 향 특성을 기술하도록 하였다.Sensory evaluation personnel consist of 3 male and female college students over 20 years of age, and a small amount of each silica gel column chromatography fraction obtained in 1-2 was wetted in paper (smelling paper), and then the solvent was volatilized and presented to the sensory evaluation personnel. Fragrance characteristics were described by (profile test).
그 결과, 분획 중 특히 n-헥산:디에틸에테르 (80:20) 혼합액으로 용출한 분획에서 천마 특유의 강한 이취가 발현되었다(표 1).As a result, in the fraction eluted with a mixture of n-hexane:diethyl ether (80:20), a strong off-flavor peculiar to Chunma was expressed (Table 1).
numberFraction
number
Hex:ethyl ether (80:20)
1-4. GC(gas chromatography) 분석1-4. Gas chromatography (GC) analysis
1-2 및 1-3에서 각각 수득한, SDE 방법으로 수증기 증류하여 얻어진 휘발성 성분 분획 및 실리카 겔 칼럼 크로마토그래피에 의해 얻어진 각 분획을 GC 방법으로 분석하였다. 구체적으로, 융합 실리카 모세관 칼럼(Supelcowax 10 fused silica capillary column, 25m x 0.32mm)을 사용하고, 칼럼 온도는 50℃에서 230℃까지 분당 2℃의 속도로 승온 후 230℃에서 20분간 유지하였다. 주입구(injector)와 검출기(detector)는 250℃로 설정하였고, 운반기체는 질소 가스(nitrogen gas)(1.0mL/분)를 사용하여 분할비(split ratio, = 20:1) 모드로 분석하였다. The volatile component fractions obtained by steam distillation by the SDE method and each fraction obtained by silica gel column chromatography obtained in 1-2 and 1-3, respectively, were analyzed by the GC method. Specifically, a fused silica capillary column (
천마를 수증기 증류하여 얻어진 휘발성 분획 및 실리카 겔 칼럼 크로마토그래피 결과 중 천마 특유의 강한 이취가 발현된 n-헥산:디에틸에테르 (80:20) 분획에서 표준품 p-크레졸(p-cresol, 4-methylphenol)(Wako, 일본)과 일치하는 큰 피크(peak)가 검출되었다(도 1). 또한, 표준품 p-크레졸과 각 분획의 냄새 특성을 관능평가를 통해 비교한 결과, n-헥산:디에틸에테르 (80:20) 분획에서 발현되는 특유의 이취(swine barn-like)는 p-크레졸과 유사한 냄새를 지니고 있었다. p-크레졸의 냄새 역치(odor threshold value)는 1 ppb로, 매우 낮은 농도에서도 특징적이면서 강한 냄새를 생성하는 것으로 알려져 있다.The volatile fraction obtained by steam distillation of Cheonma and the n-hexane:diethylether (80:20) fraction showing a strong off-odor peculiar to Cheonma among the results of silica gel column chromatography, p-cresol, 4-methylphenol ) (Wako, Japan) and a large peak was detected (Fig. 1). In addition, as a result of comparing the odor characteristics of each fraction with the standard p-cresol through sensory evaluation, the characteristic odor (swine barn-like) expressed in the n-hexane:diethyl ether (80:20) fraction was p-cresol. It had a smell similar to The odor threshold value of p-cresol is 1 ppb, which is known to generate a characteristic and strong odor even at very low concentrations.
<실시예 2> 발효천마 제조방법<Example 2> Fermentation cheonma manufacturing method
Lactobacillus plantarum VL-1(도 8, 서열번호 3)(NCBI 등록, 등록번호 KX622695), Pediococcus inopinatus BK-3(Pediococcus inopinatus BK-1(유전자은행), 기탁번호 KACC91859P, 도 7, 서열번호 2), Lactobacillus sakei C-11(기탁번호 KACC91863P, 도 6, 서열번호 1) 유산균은 MRS 배지에서 30℃로 2일간 배양하여 배양액을 수득하였다. Lactobacillus plantarum VL-1 (Figure 8, SEQ ID NO: 3) (NCBI registration, registration number KX622695), Pediococcus inopinatus BK-3 ( Pediococcus inopinatus BK-1 (gene bank), accession number KACC91859P, Figure 7, SEQ ID NO: 2), Lactobacillus sakei C-11 (Accession No. KACC91863P, Fig. 6, SEQ ID No. 1) was cultured in MRS medium at 30° C. for 2 days to obtain a culture solution.
천마 분말에 물을 전체에 대하여 0.5배로 첨가하였다(예: 분말 재료 전체 양이 500g인 경우 물 양은 250ml). 재료와 물이 잘 섞이도록 버무려 반죽한 후, 찜 솥에 40분간 쪄 증자하였다. 증자한 반죽은 적정 용기에 담고 맥아 추출맥을 첨가하여(첨가량은 재료 전체 양과 동량) 죽처럼 만들었다. 65℃ 항온수조에 중탕으로 3~5시간 동안 당화시킨 후, 121℃에서 15분간 살균하였다. 이후 30℃ 이하로 식히고 클린벤치(무균실)에서 유산균(VL-1(Lactobacillus plantarum), BK-3(Pediococcus inopinatus) 및 C-11(Lactobacillus sakei)을 각각 접종한 뒤(접종량은 재료 전체 양의 1%, 예: 재료 전체 양이 500g일 경우, 유산균 배양액 5ml 접종), 30℃에서 발효하였다. 발효된 천마는 상온에서 건조하여 분말화하였다. VL-1, BK-3 또는 C-11의 각 유산균을 이용하여 발효한 발효천마 분말 시료를 하기에서 VL-1 시료, BK-3 시료 또는 C-11 시료로 명명하였으며, 발효하지 않은 천마 분말 시료는 대조구로 사용하였다.Water was added in an amount of 0.5 times the total amount of cheonma powder (e.g., when the total amount of powdered material is 500g, the amount of water is 250ml). After mixing and kneading so that the ingredients and water were well mixed, it was steamed in a steamer for 40 minutes and increased. The steamed dough was put in an appropriate container, and malt extract was added (added equal to the total amount of the ingredients) to make it like porridge. After saccharification in a 65° C. constant temperature water bath with a water bath for 3 to 5 hours, sterilization was performed at 121° C. for 15 minutes. After cooling down to 30℃ or less, inoculate lactic acid bacteria (VL-1 (Lactobacillus plantarum ), BK-3 ( Pediococcus inopinatus ) and C-11 ( Lactobacillus sakei ) in a clean bench (clean room), respectively (inoculation amount is 1 of the total amount of the material). %, Example: When the total amount of the material is 500g, 5 ml of lactic acid bacteria culture solution was inoculated), fermented at 30° C. The fermented cheonma was dried at room temperature and powdered, each of the lactic acid bacteria of VL-1, BK-3 or C-11. The fermented cheonma powder sample fermented using was named as VL-1 sample, BK-3 sample, or C-11 sample below, and the non-fermented cheonma powder sample was used as a control.
<실시예 3> 발효천마 내 p-크레졸 분석<Example 3> Analysis of p-cresol in fermented cheonma
3-1. p-크레졸의 검량선 작성3-1. Preparation of calibration curve for p-cresol
표준품 p-크레졸 50mg을 취해 아세트산에틸 25mL에 용해하고 내부표준물질인 o-크레졸(Wako, 일본) 105.6mg을 취해 아세트산에틸 100mL에 용해하여, 검량 곡선(calibration curve)을 작성하였다(표 2 및 도 3).50 mg of the standard p-cresol was taken and dissolved in 25 mL of ethyl acetate, and 105.6 mg of the internal standard o-cresol (Wako, Japan) was taken and dissolved in 100 mL of ethyl acetate to prepare a calibration curve (Table 2 and Fig. 3).
3-2. 시료 추출3-2. Sample extraction
실시예 2의 분말 상태의 시료 2.00g을 취한 다음 50mL 용량의 코니칼 튜브에 담고 1N-HCl 용액 10mL와 내부표준물질로 사용한 o-크레졸 용액 0.5 mL (o-크레졸 528 μg 함유) 및 추출 용매인 아세트산에틸 29.5mL를 가한 후 실온에서 120 rpm으로 1주야(12시간) 진탕(shaking)하여 추출하였다. 추출된 시료는 원심분리(4,500 rpm, 20분)한 다음 아세트산에틸층 20mL를 50mL 용량의 코니칼 튜브에 취한 다음 무수 황산나트륨 6g을 가하고 3시간 동안 진탕한 후 여과하였다. 2.00 g of a powdery sample of Example 2 was taken, placed in a 50 mL conical tube, 10 mL of 1N-HCl solution, 0.5 mL of o-cresol solution used as an internal standard (containing 528 μg of o-cresol), and an extraction solvent After adding 29.5 mL of ethyl acetate, extraction was performed by shaking for 1 day and night (12 hours) at 120 rpm at room temperature. The extracted sample was centrifuged (4,500 rpm, 20 minutes), 20 mL of an ethyl acetate layer was taken into a 50 mL conical tube, 6 g of anhydrous sodium sulfate was added, shaken for 3 hours, and then filtered.
3-3. GC 분석3-3. GC analysis
여과액은 감압농축한 다음 아세톤(acetone) 1.0mL에 용해시킨 후 GC 방법으로 분석하였다. 구체적으로, 융합 실리카 모세관 칼럼(Supelcowax 10 fused silica capillary column, 25m x 0.32mm)을 사용하고, 칼럼 온도는 130℃에서 3분간 유지한 다음 230℃까지 분당 3℃의 속도로 승온 후 230℃에서 15분간 유지하였다. 주입구와 검출기는 250℃로 설정하였고, 운반기체는 질소 가스(nitrogen gas)(1.0mL/분)를 사용하여 분할비(split ratio, = 20:1) 모드로 분석하였다.The filtrate was concentrated under reduced pressure, dissolved in 1.0 mL of acetone, and analyzed by GC method. Specifically, a fused silica capillary column (
발효천마 중의 p-크레졸 함량을 분석한 결과, 발효하지 않은 대조구(천마 분말)에 비해 발효한 발효천마 분말 시료에서 p-크레졸 함량이 낮았으며, 특히, C-11 시료에서 p-크레졸 함량이 가장 낮았다(표 3).As a result of analyzing the p-cresol content in fermented cheonma, the p-cresol content in the fermented cheonma powder sample was lower than that of the non-fermented control (cheonma powder). In particular, the p-cresol content in the C-11 sample was the highest. Was low (Table 3).
<실시예 4> 발효천마 내 유용성분 함량 분석<Example 4> Analysis of the content of useful ingredients in fermented cheonma
실시예 2의 분말 상태의 시료 2.00g에 80% 메탄올(methanol) 20ml를 가한 다음 70에서 30분 간 가열하여 추출한 후 원심분리(4,500 rpm, 20분)하고 잔사는 다시 80% 메탄올 20ml를 가한 다음 70℃에서 30분간 가열하여 추출한 후 원심분리(4,500 rpm, 20분)하였다. 추출액을 합하여 감압농축한 다음 70% 메탄올 5.0ml에 용해시킨 후 여과하여 HPLC(high performance liquid chromatography) 방법으로 분석하였다. 구체적으로, 칼럼은 Eclipse XDB C18RS(4.5 x 25 cm, id 5 μm)을 사용하였고 검출기는 PDA detector (220nm)를 사용하였다. 용매는 0.1% 인산(phosphoric acid) 수용액 (A 용매)과 100% 메탄올 (B 용매)을 사용하였으며, 구배(gradient) 조건은 85%(A) 및 15%(B)(0-2분), 45%(A) 및 55%(B)(2-35분), 85%(A) 및 15%(B)(35-40분), 85%(A) 및 15%(B)(45-50분)의 비율로 하였고, 유속(flow rate)은 0.8mL/분, 주입량은 10 μL로 하였다. 각 성분은 표준품을 사용하여 표준곡선을 작성 후 정량하였다. After adding 20 ml of 80% methanol to 2.00 g of a powdery sample of Example 2, extraction was performed by heating at 70 for 30 minutes, centrifugation (4,500 rpm, 20 minutes), and 20 ml of 80% methanol was added to the residue. Extracted by heating at 70° C. for 30 minutes and centrifuged (4,500 rpm, 20 minutes). The extracts were combined, concentrated under reduced pressure, dissolved in 5.0 ml of 70% methanol, filtered, and analyzed by HPLC (high performance liquid chromatography). Specifically, Eclipse XDB C18RS (4.5 x 25 cm,
HPLC 방법으로 분석한 표준품 및 천마 시료 중의 유용성분 함량를 분석한 결과, 도 4 및 도 5와 같이, 천마 내 gastrodin (4-(hydroxymethyl)phenyl-β-D-glucopyranoside) 및 4-hydroxybenzyl alcohol 등이 함유되어 있음을 확인하였다. 이 성분들은 천마의 생리활성과 밀접한 관련이 있는 것으로 밝혀져 있다.As a result of analyzing the content of useful components in the standard and Chunma samples analyzed by the HPLC method, as shown in FIGS. 4 and 5, gastrodin (4-(hydroxymethyl)phenyl-β-D-glucopyranoside) and 4-hydroxybenzyl alcohol in Chunma are contained. It was confirmed that These ingredients have been found to be closely related to the physiological activity of Chunma.
또한, VL-1, BK-3 및 C-11 시료 중의 유용성분 함량을 분석한 결과는 표 4, 표 5 및 표 6과 같았다. VL-1 시료의 경우 발효가 진행됨에 따라 gastrodin은 증가하는 경향을 보였다. BK-3 시료 역시 VL-1 시료와 유사한 경향을 보였으나 C-11 시료의 경우 발효에 따른 성분 변화에 있어 일정한 경향을 보이지 않았다.In addition, the results of analyzing the content of useful components in the samples VL-1, BK-3, and C-11 were shown in Tables 4, 5, and 6. In the case of the VL-1 sample, gastrodin tended to increase as fermentation proceeded. The BK-3 sample also showed a similar tendency to that of the VL-1 sample, but the C-11 sample did not show a certain tendency in terms of the composition change due to fermentation.
<실시예 5> 발효천마의 항산화 효과, 총 플라보노이드 및 총 폴리페놀 함량 검정<Example 5> Antioxidant effect of fermented cheonma, total flavonoid and total polyphenol content assay
5-1. DPPH(2,2-diphenyl-1-picrylhydrazyl) 분석5-1. DPPH (2,2-diphenyl-1-picrylhydrazyl) analysis
실시예 2에서 제조한 발효천마 분말 시료 및 대조구(천마 분말) 시료를 대상으로 DPPH 분석을 수행하였다. DPPH 라디칼 소거 활성은 Blois 등(1958)의 방법을 변형하여 측정하였다. 구체적으로, 시료 0.1 ml에 0.1M Tri 0.4ml를 넣고 혼합한 후 500 μM로 제조한 DPPH 용액 0.5 mL을 96-웰 플레이트에서 첨가하여 잘 섞은 후 실온에서 20 분간 반응시키고 UV 분광광도계를 이용하여 517 nm에서 흡광도를 측정하였다. 음성대조구는 시료 대신 증류수를 넣어 측정하였다. DPPH 라디칼 소거 활성은 아래와 같은 식으로 계산하여 백분율(%)로 표시하였으며, 표 7에 나타냈다. 양성대조구로 BHT(dibutyl hydroxy toluene) 및 BHA(butylated hydroxy anisole)를 사용하였다.DPPH analysis was performed on the fermented cheonma powder sample and the control (cheonma powder) sample prepared in Example 2. DPPH radical scavenging activity was measured by modifying the method of Blois et al. (1958). Specifically, 0.4 ml of 0.1M Tri was added to 0.1 ml of a sample, mixed, 0.5 ml of a DPPH solution prepared in 500 μM was added in a 96-well plate, mixed well, reacted at room temperature for 20 minutes, and then 517 The absorbance was measured at nm. The negative control was measured by putting distilled water instead of the sample. DPPH radical scavenging activity was calculated by the following equation and expressed as a percentage (%), and is shown in Table 7. BHT (dibutyl hydroxy toluene) and BHA (butylated hydroxy anisole) were used as positive controls.
DPPH 라디칼 소거 활성 (%) = DPPH radical scavenging activity (%) =
[1-(실험구 흡광도/음성대조구 흡광도)] × 100 [1-(Experimental area absorbance/Negative control area absorbance)] × 100
그 결과, VL-1 시료는 발효 6일째 83.61%의 소거 활성을 나타내었고, BK-3은 발효 4일째 76.72%의 소거활성을 나타내었으며, C-11은 발효 6일째 82.88%의 소거 활성을 나타내었다. 발효 2일째부터는 모든 발효천마 분말 시료에서 천마 분말 또는 양성대조구인 BHT 및 BHA에 비해 우수한 DPPH 소거 활성이 나타나는 것을 확인하였다. As a result, VL-1 sample showed 83.61% scavenging activity on the 6th day of fermentation, BK-3 showed 76.72% of scavenging activity on the 4th day of fermentation, and C-11 showed 82.88% scavenging activity on the 6th day of fermentation. I got it. From the second day of fermentation, it was confirmed that all fermented Cheonma powder samples showed superior DPPH scavenging activity compared to Cheonma powder or positive controls BHT and BHA.
5-2. FRAP(Ferric reducing antioxidant power) 분석 5-2. FRAP(Ferric reducing antioxidant power) analysis
실시예 2에서 제조한 발효천마 분말 시료 및 대조구(천마 분말) 시료를 대상으로 FRAP 분석을 수행하였다. 구체적으로, 반응액으로 300mM 아세테이트 완충액(pH 3.6), 40 mM 염산에 녹인 10 mM 2,4,6-트리피리딜-s-트리아진(TPTZ, T1253, C18H12N6, MW312.33) 및 20mM FeCl3(F7134, MW 162.20)를 준비하였으며, 아세테이트 완충액, TPTZ 용액 및 FeCl3 용액을 10:1:1 (v/v/v)로 혼합하여 37℃ 에서 15분 간 예비반응을 시켜두었다. 시료 0.15 ml과 예비반응된 FRAP 시약 2.85 ml을 섞어 15분간 반응시키고 마이크로플레이트 리더(Biorad 3055, 스웨덴)를 사용하여 593 nm에서 흡광도를 측정하였다. FeSO4·7H2O을 이용하여 작성한 표준곡선으로부터 함량(ppm)을 구하였으며, 표 8에 나타냈다.FRAP analysis was performed on the fermented cheonma powder sample and the control (cheonma powder) sample prepared in Example 2. Specifically, as a reaction solution, 300 mM acetate buffer (pH 3.6), 10
그 결과, 발효 6일째에 VL-1 시료는 532.7 ppm, BK-3 시료는 375.0 ppm, C-11 시료는 584.6 ppm으로 나타났으며, 모든 발효천마 분말 시료는 천마 분말 시료에 비해 우수한 효과를 나타내었다.As a result, on the 6th day of fermentation, the VL-1 sample was 532.7 ppm, the BK-3 sample was 375.0 ppm, and the C-11 sample was 584.6 ppm. I got it.
5-3. 총 플라보노이드 함량 분석 5-3. Total flavonoid content analysis
실시예 2에서 제조한 발효천마 분말 시료 및 대조구(천마 분말) 시료를 대상으로 총 플라보노이드 함량을 분석하였다. 총 플라보노이드 함량은 Davis 변법(2010)에 따라, 시료 0.1 mL에 디에틸렌글리콜(diethylene glycol) 0.15 mL를 가하여 혼합하고 이어서 1N-NaOH 용액 20 μl를 가한 다음 혼합 후 37℃에서 1시간 동안 반응하고 420nm에서 흡광도를 측정하였다. 루틴(rutin)을 이용하여 작성한 검량곡선으로부터 총 플라보노이드 함량을 구하고 ppm으로 표시하였으며, 표 9에 나타내었다.The total flavonoid content was analyzed for the fermented cheonma powder sample and the control (cheonma powder) sample prepared in Example 2. The total flavonoid content was mixed by adding 0.15 mL of diethylene glycol to 0.1 mL of a sample according to the Davis variant (2010), followed by adding 20 μl of a 1N-NaOH solution, followed by mixing and reacting at 37° C. for 1 hour, followed by 420 nm. The absorbance was measured at. The total flavonoid content was calculated from the calibration curve prepared using rutin and expressed in ppm, and is shown in Table 9.
그 결과, VL-1 시료는 발효 6일째에 108.92 ppm, BK-3 시료는 발효 4일째에 78.06 ppm, C-11 시료는 발효 6일째에 99.40 ppm으로 나타났으며, 모든 발효천마 분말 시료는 천마 분말 시료에 비해 우수한 총 플라보노이드 함량을 나타내었다.As a result, the VL-1 sample was found to be 108.92 ppm on the 6th day of fermentation, the BK-3 sample was 78.06 ppm on the 4th day of fermentation, and the C-11 sample was 99.40 ppm on the 6th day of fermentation. It showed superior total flavonoid content compared to the powder sample.
5-4. 총 폴리페놀 함량 분석5-4. Analysis of total polyphenol content
실시예 2에서 제조한 발효천마 분말 시료 및 대조구(천마 분말) 시료를 대상으로 총 폴리페놀 함량을 분석하였다. 총 폴리페놀 함량은 Folins-Denis 방법으로 측정하였다. 구체적으로, 시료 0.2 mL에 증류수 0.8 mL을 넣고 2N 폴린-시오칼토 시약(Folin-ciocalteu reagent) 0.1 mL를 가하여 혼합, 3분간 정치 후 2% Na2CO3 용액 0.2 mL에 증류수 0.7 mL를 첨가하였다. 혼합액을 1시간 동안 반응시킨 후 분광광도계(UV/VIS spectrometer, 일본)를 사용하여 Abs750에서 흡광도를 측정하고, 표준물질 탄닌산을 이용하여 작성한 표준곡선으로부터 총 폴리페놀 함량(ppm)을 구하였으며, 표 10에 나타내었다.The total polyphenol content was analyzed for the fermented cheonma powder sample and the control (cheonma powder) sample prepared in Example 2. The total polyphenol content was determined by the Folins-Denis method. Specifically, 0.8 mL of distilled water was added to 0.2 mL of the sample, 0.1 mL of 2N Folin-ciocalteu reagent was added, mixed, allowed to stand for 3 minutes, and 0.7 mL of distilled water was added to 0.2 mL of a 2% Na 2 CO 3 solution. . After reacting the mixture for 1 hour, the absorbance was measured in Abs750 using a spectrophotometer (UV/VIS spectrometer, Japan), and the total polyphenol content (ppm) was calculated from the standard curve prepared using the standard tannic acid. It is shown in 10.
그 결과, VL-1 시료는 발효 6일째에 193.5 ppm, BK-3 시료는 발효 4일째에 159.5 ppm, C-11 시료는 발효 4일째에 204.2 ppm으로 나타났으며, 모든 발효천마 분말 시료는 천마 분말 시료에 비해 우수한 총 폴리페놀 함량을 나타내었다.As a result, the VL-1 sample was 193.5 ppm on the 6th day of fermentation, the BK-3 sample was 159.5 ppm on the 4th day of fermentation, and the C-11 sample was 204.2 ppm on the 4th day of fermentation. It showed superior total polyphenol content compared to the powder sample.
<110> Chonbuk-do Agricultural Research and Extension Services <120> Method for fermented Gastrodia elata BL using lactic acid bacteria <130> DHP16-576 <160> 3 <170> KoPatentIn 3.0 <210> 1 <211> 1474 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Lactobacillus sakei C-11 <400> 1 atgcgggtgc tataatgcag tcgaacgcac tctcgtttag attgaaggag cttgctcctg 60 attgataaac atttgagtga gtggcggacg ggtgagtaac acgtgggtaa cctgccctaa 120 agtgggggat aacatttgga aacagatgct aataccgcat aaaacctaac accgcatggt 180 gtagggttga aagatggttt cggctatcac tttaggatgg acccgcggtg cattagttag 240 ttggtgaggt aaaggctcac caagaccgtg atgcatagcc gacctgagag ggtaatcggc 300 cacactggga ctgagacacg gcccagactc ctacgggagg cagcagtagg gaatcttcca 360 caatggacga aagtctgatg gagcaacgcc gcgtgagtga agaaggtttt cggatcgtaa 420 aactctgttg ttggagaaga atgtatctga tagtaactga tcaggtagtg acggtatcca 480 accagaaagc cacggctaac tacgtgccag cagccgcggt aatacgtagg tggcaagcgt 540 tgtccggatt tattgggcgt aaagcgagcg caggcggttt cttaagtctg atgtgaaagc 600 ctttcggctc aaccgaagaa gtgcatcgga aactgggaaa cttgagtgca gaagaggaca 660 gtggaactcc atgtgtagcg gtgaaatgcg tagatatatg gaagaacacc agtggcgaag 720 gcggctgtct ggtctgtaac tgacgctgag gctcgaaagc atgggtagca aacaggatta 780 gataccctgg tagtccatgc cgtaaacgat gagtgctagg tgttggaggg tttccgccct 840 tcagtgccgc agctaacgca ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa 900 ctcaaaggaa ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa 960 cgcgaagaac cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct 1020 tcggggacaa agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg 1080 ttaagtcccg caacgagcgc aacccttatt actagttgcc agcatttagt tgggcactct 1140 agtgagactg ccggtgacaa accggaggaa ggtggggacg acgtcaaatc atcatgcccc 1200 ttatgacctg ggctacacac gtgctacaat ggatggtaca acgagttgcg agaccgcgag 1260 gtttagctaa tctcttaaaa ccattctcag ttcggattgt aggctgcaac tcgcctacat 1320 gaagccggaa tcgctagtaa tcgcggatca gcatgccgcg gtgaatacgt tcccgggcct 1380 tgtacacacc gcccgtcaca ccatgagagt ttgtaacacc caaagccggt gaggtaaccc 1440 ttcggggagc cagccgtcta atgtgacaga tgtt 1474 <210> 2 <211> 1228 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Pediococcus inopinatus BK-3 <400> 2 gctagttggt gagataaagg cccaccaagg ctgtgatacg tagccgacct gagagggtaa 60 tcggccacat tgggactgag acacggccca gactcctacg ggaggcagca gtagggaatc 120 ttccacaatg gacgaaagtc tgatggagca acgccgcgtg agtgatgaag gctttagggt 180 cgtaaaactc tgttgntgga gaagaacgtg tgtgagagta actgctcatg cagtgacggt 240 atccaaccag aaagccacgg ctaactacgt gccagcagcc gcggtaatac gtaggtggca 300 agcgttatcc ggatttattg ggcgtaaagc gagcgcaggc ggtttcttaa gtctaatgtg 360 aaagccttcg gcttaaccga agaagtgcat tggaaactgg gaaacttgag tgcagaagag 420 gacagtggaa ctccatgtgt agcggtgaaa tgcgtagata tatggaagaa caccagtggc 480 gaaggcggct gtctggtctg taactgacgc tgaggctcga aagcatgggt agcgaacagg 540 attagatacc ctggtagtcc atgccgtaaa cgatgaatgc taagtgttgg agggtttccg 600 cccttcagtg ctgcagctaa cgcattaagc attccgcctg gggagtacga ccgcaaggtt 660 gaaactcaaa agaattgacg ggggcccgca caagcggtgg agcatgtggt ttaattcgaa 720 gctacgcgaa gaaccttacc aggtcttgac atcttctgct aacctaagag attaggcgtt 780 cccttcgggg acagaatgac aggtggtgca tggttgtcgt cagctcgtgt cgtgagatgt 840 tgggttaagt cccgcaacga gcgcaacccc tattattagt tgccagcatt aagttgggca 900 ctctagtgag actgccggtg ataaaccgga ggaaggtggg gacgacgtca aatcatcatg 960 ccccttatga cctgggctac acacgtgcta caatggacgg tacaacgagt tgcgagaccg 1020 cgaggttaag ctaatctctt aaaaccgttc tcagttcgga ctgcaggctg caactcgcct 1080 gcacgaagtt ggaatcgcta gtaatcgcgg atcagcatgc cgcggtgaat acgttcccgg 1140 gccttgtaca caccgcccgt cacaccatga gagtttgtaa cacccaaagc cggtggagta 1200 accttcggga gctagccgtc taagtgac 1228 <210> 3 <211> 1431 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Lactobacillus plantarum VL-1 <400> 3 tcgacgaact ctggtattga ttggtgcttg catcatgatt tacatttgag tgagtggcga 60 actggtgagt aacacgtggg aaacctgccc agaagcgggg gataacacct ggaaacagat 120 gctaataccg cataacaact tggaccgcat ggtccgagct tgaaagatgg cttcggctat 180 cacttttgga tggtcccgcg gcgtattagc tagatggtga ggtaacggct caccatggca 240 atgatacgta gccgacctga gagggtaatc ggccacattg ggactgagac acggcccaaa 300 ctcatacggg aggcagcagt agggaatctt ccacaatgga cgaaagtctg atggagcaac 360 gccgcgtgag tgaagaaggg tttcggctcg taaaactctg ttgttaaaga agaacatatc 420 tgagagtaac tgttcaggta ttgacggtat ttaaccagaa agccacggct aactacgtgc 480 cagcagccgc ggtaatacgt aggtggcaag cgttgtccgg atttattggg cgtaaagcga 540 gcgcaggcgg ttttttaagt ctgatgtgaa agccttcggc tcaaccgaag aagtgcatcg 600 gaaactggga aacttgagtg cagaagagga cagtggaact ccatgtgtag cggtgaaatg 660 cgtagatata tggaagaaca ccagtggcga aggcggctgt ctggtctgta actgacgctg 720 aggctcgaaa gtatgggtag caaacaggat tagataccct ggtagtccat accgtaaacg 780 atgaatgcta agtgttggag ggtttccgcc cttcagtgct gcagctaacg cattaagcat 840 tccgcctggg gagtacggcc gcaaggctga aactcaaagg aattgacggg ggcccgcaca 900 agcggtggag catgtggttt aattcgaagc tacgcgaaga accttaccag gtcttgacat 960 actatgcaaa tctaagagat tagacgttcc cttcggggac atggatacag gtggtgcatg 1020 gttgtcgtca gctcgtgtcg tgagatgttg ggttaagtcc cgcaacgagc gcaaccctta 1080 ttatcagttg ccagcattaa gttgggcact ctggtgagac tgccggtgac aaaccggagg 1140 aaggtgggga tgacgtcaaa tcatcatgcc ccttatgacc tgggctacac acgtgctaca 1200 atggatggta caacgagttg cgaactcgcg agagtaagct aatctcttaa agccattctc 1260 agttcggatt gtaggctgca actcgcctac atgaagtcgg aatcgctagt aatcgcggat 1320 cagcatgccg cggtgaatac gttcccgggc cttgtacaca ccgcccgtca caccatgaga 1380 gtttgtaaca cccaaagtcg gtggggtaac cttttaggaa ccagccgcct a 1431 <110> Chonbuk-do Agricultural Research and Extension Services <120> Method for fermented Gastrodia elata BL using lactic acid bacteria <130> DHP16-576 <160> 3 <170> KoPatentIn 3.0 <210> 1 <211> 1474 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Lactobacillus sakei C-11 <400> 1 atgcgggtgc tataatgcag tcgaacgcac tctcgtttag attgaaggag cttgctcctg 60 attgataaac atttgagtga gtggcggacg ggtgagtaac acgtgggtaa cctgccctaa 120 agtgggggat aacatttgga aacagatgct aataccgcat aaaacctaac accgcatggt 180 gtagggttga aagatggttt cggctatcac tttaggatgg acccgcggtg cattagttag 240 ttggtgaggt aaaggctcac caagaccgtg atgcatagcc gacctgagag ggtaatcggc 300 cacactggga ctgagacacg gcccagactc ctacgggagg cagcagtagg gaatcttcca 360 caatggacga aagtctgatg gagcaacgcc gcgtgagtga agaaggtttt cggatcgtaa 420 aactctgttg ttggagaaga atgtatctga tagtaactga tcaggtagtg acggtatcca 480 accagaaagc cacggctaac tacgtgccag cagccgcggt aatacgtagg tggcaagcgt 540 tgtccggatt tattgggcgt aaagcgagcg caggcggttt cttaagtctg atgtgaaagc 600 ctttcggctc aaccgaagaa gtgcatcgga aactgggaaa cttgagtgca gaagaggaca 660 gtggaactcc atgtgtagcg gtgaaatgcg tagatatatg gaagaacacc agtggcgaag 720 gcggctgtct ggtctgtaac tgacgctgag gctcgaaagc atgggtagca aacaggatta 780 gataccctgg tagtccatgc cgtaaacgat gagtgctagg tgttggaggg tttccgccct 840 tcagtgccgc agctaacgca ttaagcactc cgcctgggga gtacgaccgc aaggttgaaa 900 ctcaaaggaa ttgacggggg cccgcacaag cggtggagca tgtggtttaa ttcgaagcaa 960 cgcgaagaac cttaccaggt cttgacatcc tttgaccact ctagagatag agctttccct 1020 tcggggacaa agtgacaggt ggtgcatggt tgtcgtcagc tcgtgtcgtg agatgttggg 1080 ttaagtcccg caacgagcgc aacccttatt actagttgcc agcatttagt tgggcactct 1140 agtgagactg ccggtgacaa accggaggaa ggtggggacg acgtcaaatc atcatgcccc 1200 ttatgacctg ggctacacac gtgctacaat ggatggtaca acgagttgcg agaccgcgag 1260 gtttagctaa tctcttaaaa ccattctcag ttcggattgt aggctgcaac tcgcctacat 1320 gaagccggaa tcgctagtaa tcgcggatca gcatgccgcg gtgaatacgt tcccgggcct 1380 tgtacacacc gcccgtcaca ccatgagagt ttgtaacacc caaagccggt gaggtaaccc 1440 ttcggggagc cagccgtcta atgtgacaga tgtt 1474 <210> 2 <211> 1228 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Pediococcus inopinatus BK-3 <400> 2 gctagttggt gagataaagg cccaccaagg ctgtgatacg tagccgacct gagagggtaa 60 tcggccacat tgggactgag acacggccca gactcctacg ggaggcagca gtagggaatc 120 ttccacaatg gacgaaagtc tgatggagca acgccgcgtg agtgatgaag gctttagggt 180 cgtaaaactc tgttgntgga gaagaacgtg tgtgagagta actgctcatg cagtgacggt 240 atccaaccag aaagccacgg ctaactacgt gccagcagcc gcggtaatac gtaggtggca 300 agcgttatcc ggatttattg ggcgtaaagc gagcgcaggc ggtttcttaa gtctaatgtg 360 aaagccttcg gcttaaccga agaagtgcat tggaaactgg gaaacttgag tgcagaagag 420 gacagtggaa ctccatgtgt agcggtgaaa tgcgtagata tatggaagaa caccagtggc 480 gaaggcggct gtctggtctg taactgacgc tgaggctcga aagcatgggt agcgaacagg 540 attagatacc ctggtagtcc atgccgtaaa cgatgaatgc taagtgttgg agggtttccg 600 cccttcagtg ctgcagctaa cgcattaagc attccgcctg gggagtacga ccgcaaggtt 660 gaaactcaaa agaattgacg ggggcccgca caagcggtgg agcatgtggt ttaattcgaa 720 gctacgcgaa gaaccttacc aggtcttgac atcttctgct aacctaagag attaggcgtt 780 cccttcgggg acagaatgac aggtggtgca tggttgtcgt cagctcgtgt cgtgagatgt 840 tgggttaagt cccgcaacga gcgcaacccc tattattagt tgccagcatt aagttgggca 900 ctctagtgag actgccggtg ataaaccgga ggaaggtggg gacgacgtca aatcatcatg 960 ccccttatga cctgggctac acacgtgcta caatggacgg tacaacgagt tgcgagaccg 1020 cgaggttaag ctaatctctt aaaaccgttc tcagttcgga ctgcaggctg caactcgcct 1080 gcacgaagtt ggaatcgcta gtaatcgcgg atcagcatgc cgcggtgaat acgttcccgg 1140 gccttgtaca caccgcccgt cacaccatga gagtttgtaa cacccaaagc cggtggagta 1200 accttcggga gctagccgtc taagtgac 1228 <210> 3 <211> 1431 <212> RNA <213> Unknown <220> <223> 16S ribosomal RNA gene of Lactobacillus plantarum VL-1 <400> 3 tcgacgaact ctggtattga ttggtgcttg catcatgatt tacatttgag tgagtggcga 60 actggtgagt aacacgtggg aaacctgccc agaagcgggg gataacacct ggaaacagat 120 gctaataccg cataacaact tggaccgcat ggtccgagct tgaaagatgg cttcggctat 180 cacttttgga tggtcccgcg gcgtattagc tagatggtga ggtaacggct caccatggca 240 atgatacgta gccgacctga gagggtaatc ggccacattg ggactgagac acggcccaaa 300 ctcatacggg aggcagcagt agggaatctt ccacaatgga cgaaagtctg atggagcaac 360 gccgcgtgag tgaagaaggg tttcggctcg taaaactctg ttgttaaaga agaacatatc 420 tgagagtaac tgttcaggta ttgacggtat ttaaccagaa agccacggct aactacgtgc 480 cagcagccgc ggtaatacgt aggtggcaag cgttgtccgg atttattggg cgtaaagcga 540 gcgcaggcgg ttttttaagt ctgatgtgaa agccttcggc tcaaccgaag aagtgcatcg 600 gaaactggga aacttgagtg cagaagagga cagtggaact ccatgtgtag cggtgaaatg 660 cgtagatata tggaagaaca ccagtggcga aggcggctgt ctggtctgta actgacgctg 720 aggctcgaaa gtatgggtag caaacaggat tagataccct ggtagtccat accgtaaacg 780 atgaatgcta agtgttggag ggtttccgcc cttcagtgct gcagctaacg cattaagcat 840 tccgcctggg gagtacggcc gcaaggctga aactcaaagg aattgacggg ggcccgcaca 900 agcggtggag catgtggttt aattcgaagc tacgcgaaga accttaccag gtcttgacat 960 actatgcaaa tctaagagat tagacgttcc cttcggggac atggatacag gtggtgcatg 1020 gttgtcgtca gctcgtgtcg tgagatgttg ggttaagtcc cgcaacgagc gcaaccctta 1080 ttatcagttg ccagcattaa gttgggcact ctggtgagac tgccggtgac aaaccggagg 1140 aaggtgggga tgacgtcaaa tcatcatgcc ccttatgacc tgggctacac acgtgctaca 1200 atggatggta caacgagttg cgaactcgcg agagtaagct aatctcttaa agccattctc 1260 agttcggatt gtaggctgca actcgcctac atgaagtcgg aatcgctagt aatcgcggat 1320 cagcatgccg cggtgaatac gttcccgggc cttgtacaca ccgcccgtca caccatgaga 1380 gtttgtaaca cccaaagtcg gtggggtaac cttttaggaa ccagccgcct a 1431
Claims (1)
천마 분말 및 물을 2:1 중량비로 혼합한 후 증자하는 단계;
상기 증자된 천마 분말을 당화하는 단계;
상기 당화된 천마 분말을 살균하는 단계; 및
상기 살균된 천마 분말에 천마 분말 대비 1 중량%의 유산균 락토바실러스 사케아이(Lactobacillus sakei C-11, 기탁번호 KACC91863P)를 접종하여 2일 내지 4일간 발효하는 단계;를 포함하는 유산균을 이용한 p-크레졸 함량이 감소된 발효천마의 제조방법.As a method for producing a fermented horse meat using lactic acid bacteria,
Mixing the powder of rhizome with water at a weight ratio of 2: 1 and then adding the mixture;
Saccharifying the donated glucose-containing powder;
Sterilizing the saccharified chewing gum powder; And
And a step of inoculating 1% by weight of Lactobacillus sakei C-11 (accession number KACC91863P) to the sterilized chitosan powder and fermenting the mixture for 2 days to 4 days, and p-cresol A method for producing a fermented chicken meat having reduced content.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180105154A KR101981181B1 (en) | 2018-09-04 | 2018-09-04 | Method for fermented Gastrodia elata BL using lactic acid bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180105154A KR101981181B1 (en) | 2018-09-04 | 2018-09-04 | Method for fermented Gastrodia elata BL using lactic acid bacteria |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160145910A Division KR20180049682A (en) | 2016-11-03 | 2016-11-03 | Method for fermented Gastrodia elata BL using lactic acid bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180102524A KR20180102524A (en) | 2018-09-17 |
KR101981181B1 true KR101981181B1 (en) | 2019-05-22 |
Family
ID=63721907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180105154A KR101981181B1 (en) | 2018-09-04 | 2018-09-04 | Method for fermented Gastrodia elata BL using lactic acid bacteria |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101981181B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102496820B1 (en) * | 2019-11-22 | 2023-02-07 | 대한민국 | Method for producing Gastrodia elata with reduced unpleasant odor |
KR102622366B1 (en) * | 2020-10-30 | 2024-01-08 | 전라북도(농업기술원) | Method for fermented Gastrodia elata using Mushroom Mycelia |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100877186B1 (en) | 2007-10-12 | 2009-01-07 | 김범동 | The manufacturing process of the honeyed gastrodia elata fermented kimchi lacttcacid bacteria and it's product |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120000203A (en) * | 2010-06-25 | 2012-01-02 | 무주군약초영농조합법인 | Ferment method of gastrodia elata blume |
KR20120125152A (en) * | 2011-05-06 | 2012-11-14 | 주식회사 비피도 | Antioxidant or blood pressure regulating food composition containing the extract of Gastrodiae rhizoma fermented by lactic acid bacteria |
KR20140080756A (en) * | 2012-12-18 | 2014-07-01 | 재단법인 전주생물소재연구소 | Method for producing fermented Gastrodiae rhizoma with increased functionality using mixed fermentation strain and fermented Gastrodiae rhizoma produced by the method |
KR101703550B1 (en) * | 2014-01-13 | 2017-02-22 | 전라북도(농업기술원) | Method for preparing fermented Gastrodia elata BL using plant originated lactic acid bacteria |
KR101609130B1 (en) * | 2014-02-12 | 2016-04-05 | 무주덕유산반딧골영농조합법인 | Fermented extract of gastrodia elata with excellant antioxident activity and taste, and manufacturing method thereof |
-
2018
- 2018-09-04 KR KR1020180105154A patent/KR101981181B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100877186B1 (en) | 2007-10-12 | 2009-01-07 | 김범동 | The manufacturing process of the honeyed gastrodia elata fermented kimchi lacttcacid bacteria and it's product |
Also Published As
Publication number | Publication date |
---|---|
KR20180102524A (en) | 2018-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Filannino et al. | Lactic acid fermentation of cactus cladodes (Opuntia ficus-indica L.) generates flavonoid derivatives with antioxidant and anti-inflammatory properties | |
Juan et al. | Enhancement of antioxidant activity, total phenolic and flavonoid content of black soybeans by solid state fermentation with Bacillus subtilis BCRC 14715 | |
Wang et al. | Improvement of animal feed additives of Ginkgo leaves through solid-state fermentation using Aspergillus niger | |
CA2682755C (en) | Fermented plant extracts, methods of production and uses | |
Lee et al. | Quality and antioxidant activity of ginseng seed processed by fermentation strains | |
Sharath et al. | Bio-detoxification of phorbol esters and other anti-nutrients of Jatropha curcas seed cake by fungal cultures using solid-state fermentation | |
KR101981181B1 (en) | Method for fermented Gastrodia elata BL using lactic acid bacteria | |
KR101314762B1 (en) | Manufacturing method of Fermented material extracted from ginseng seed and fermented food thereof | |
Wang et al. | Phenolics from noni (Morinda citrifolia L.) fruit alleviate obesity in high fat diet-fed mice via modulating the gut microbiota and mitigating intestinal damage | |
CN104905158A (en) | Kluyveromyces marxianus fermented bean residue powder | |
KR101963978B1 (en) | Composition of fermented sprout ginseng having increased ginsenosides Rh2 and compound K, bioactive components, and preparation method thereof | |
KR102386870B1 (en) | Method of Cultivating Sprout Peanuts for Increasing Anti-Obesity Useful Ingredients | |
KR100844185B1 (en) | The manfacturing method of fermentation artemisia tea with lactic acid | |
KR101980450B1 (en) | Composition of active wild-cultivated ginseng having increased ginsenoside Rd and compound K, chlorgenic acid and quercetin, and preparation method thereof | |
Lee et al. | Deglycosylation of isoflavones in isoflavone-rich soy germ flour by Aspergillus oryzae KACC 40247 | |
KR20180049682A (en) | Method for fermented Gastrodia elata BL using lactic acid bacteria | |
KR101356611B1 (en) | Vinegar of fermented pepper leaf with increased AGI activity and method for preparing the same | |
Majumder et al. | Brewing and biochemical characterization of Camellia japonica petal wine with comprehensive discussion on metabolomics | |
Yan et al. | Antioxidant capacity, flavor and physicochemical properties of FH06 functional beverage fermented by lactic acid bacteria: a promising method to improve antioxidant activity and flavor of plant functional beverage | |
KR101815925B1 (en) | Fermentated Composition of Barley Sprouts Dnhanced Policosanol and Method For Composition Thereof | |
KR101703550B1 (en) | Method for preparing fermented Gastrodia elata BL using plant originated lactic acid bacteria | |
KR101917534B1 (en) | Vegetable Brown Sauce with enhanced taste and anti-oxydant property and preparation method thereof | |
KR102001632B1 (en) | Platycodon radix composition containing high protocatechuic acid, epicatechin, and oleic acid and enhanced inhibition activities of alpha-glucosidase and pancreatic lipase, and preparation method thereof | |
Wang et al. | Effects of Eucommia ulmoides Oliver leaves on gut microbiota and intestinal function during in vitro simulated digestion and fermentation | |
Martínez et al. | Mescal an alcoholic beverage from Agave spp. with great commercial potential |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |